Pulmonary Tumor Embolism  by Shigematsu, Hisayuki et al.
and those with enlarged (10 mm) but
PET negative lymph nodes. All pa-
tients in whom mediastinal staging is
negative go forward for surgical resec-
tion with systematic lymph node sam-
pling or dissection. Data from this
study may also help to address the
issue about what should be done for
those with enlarged but PET negative
mediastinal nodes.
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Pulmonary Tumor
Embolism
To the Editor:
We read with interest the recent
report by Kridel et al.1 describing a
rare case of pulmonary tumor embo-
lism (PTE) with elevated level of se-
rum D-dimer causing an acute right
heart failure.
We would like to add the follow-
ing comment. The clinical entity of pul-
monary tumor thrombotic microangi-
opathy (PTTM) that is a distinct form of
PTE is not adequately discussed in their
manuscript. PTTM, first reported by von
Herbay in 1990, is characterized by fi-
brocellular intimal proliferation of small
pulmonary arteries and arterioles in pa-
tients with cancer (especially adenocar-
cinoma).2 They stressed that the mor-
phologic findings in PTTM were
different from microscopic PTE as re-
ported previously.3 The prominent fea-
ture of PTTM is that tumor emboli
induce both local activation of the coag-
ulation system and fibrocellular intimal
proliferation, leading to the luminal ste-
nosis or occlusion in the affected ves-
sels. Clinically, patient with PTTM pre-
sents progressive dyspnea and an acute
right heart failure due to pulmonary hy-
pertension, and its prognosis is quite
dismal. A definitive diagnosis of PTTM
based on surgical lung biopsy is quiet
difficult antemortem due to its aggres-
siveness. Miyano et al.4 reported a suc-
cessfully diagnosed and treated case of
PTTM of that patient with a history of
gastric adenocarcinoma presented a dry
cough and showed an elevated level of
serum D-dimer (8900 g/L). As the au-
thors discussed, the elevation of D-dimer
level should be explained by the activa-
tion of coagulation, which is a specific
feature in PTTM.
We therefore believe that this case
is consistent with PTTM rather than
PTE in terms of the abnormality of co-
agulation cascade.
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In Response:
We thank Shigematsu et al. for
drawing our attention on the entity of
pulmonary tumor thrombotic microangi-
opathy (PTTM) that was first described
by von Herbay et al.1 These authors
pointed out that the morphologic find-
ings are different in PTTM and pulmo-
nary tumor embolism (PTE), as illus-
trated by the comparison of their cases
and those of previous descriptions.
PTTM is characterized by activation of
the coagulation cascade induced by tu-
mor cells in the lung vasculature, result-
ing in obstructive thrombosis and inti-
mal proliferation. PTE was described by
Winterbauer et al.2 as pulmonary vascu-
lar obstruction by tumor emboli.
In our case report,3 the lung his-
tology revealed that, whereas most of
small lung arteries were entirely occluded
with tumor emboli, only a minority of
vessels was affected both by tumor emboli
and thrombi. We therefore believe that our
case report is compatible with descriptions
of PTE rather than PTTM, despite the
elevated D-dimer level.
We doubt that the distinction be-
tween the two entities can currently be
established in a clear-cut manner. In-
deed, Kane et al.4 have reported that
tumor emboli to the lung vasculature are
frequently associated with thrombi and
later descriptions of PTE also high-
lighted that thrombosis and intimal
proliferation often accompany tumor
emboli.5,6 Further research seems thus
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